文献速递生殖医学

人乳头瘤病毒感染对体外受精结局的影响:系统综述与Meta分析

Effect of human papilloma virus infection on in-vitro fertilization outcome: systematic review and meta-analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2018-01-01

该系统综述与Meta分析检索截至2017年3月的多个数据库,纳入14项研究,其中10项定量分析包括299例HPV感染女性和2049例无感染女性。合并结果显示HPV感染女性与未感染女性在活产/持续妊娠、临床妊娠和流产率上无显著差异,但男性伴侣感染时活产/持续妊娠率显著降低且流产率显著升高,证据质量极低。

要点

  • 女性HPV感染与IVF后活产/持续妊娠、临床妊娠和流产率无显著差异。
  • 男性伴侣HPV感染时活产/持续妊娠率显著降低(RR 0.43),流产率显著升高(RR 3.70)。
  • 总体证据质量极低,男性伴侣感染的发现需谨慎解读。

核心结论

  • 现有证据仍不足以对女性HPV感染对IVF后最重要生殖结局的影响得出确切结论;但提示其对活产/持续妊娠率和临床妊娠率的影响不大。
  • 当男性伴侣存在感染时,似乎对活产/持续妊娠率有负面影响且流产率增加,由于支持证据质量极低,此发现应谨慎解读。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、EMBASE、Scopus、Lilacs和Cochrane Central Register of Controlled Trials从建库至2017年3月。
  • 纳入14项符合条件的研究,其中10项研究的定量数据纳入分析,评估299例HPV感染女性和2049例无HPV感染女性。
  • 采用随机效应模型评估相对风险(RR),使用I²统计量评估异质性,采用GRADE工作组推荐评估证据质量。

主要发现

  • HPV感染女性与未感染女性在活产/持续妊娠率上无显著差异(RR 1.16,95% CI 0.88-1.53;I²=0%;6项研究,983例女性)。
  • HPV感染女性与未感染女性在临床妊娠率上无显著差异(RR 1.06,95% CI 0.74-1.54;I²=61%;8项研究,1173例女性)。
  • HPV感染女性与未感染女性在流产率上无显著差异(RR 1.58,95% CI 0.93-2.69;I²=8%;6项研究,290例临床妊娠)。
  • 基于男性伴侣感染状态的亚组分析显示活产/持续妊娠率有显著差异(RR 0.43,95% CI 0.23-0.82;I²=0%;3项研究,429名参与者;P=0.01)。
  • 基于男性伴侣感染状态的亚组分析显示流产率有显著差异(RR 3.70,95% CI 1.94-7.05;I²=0%;2项研究,90名参与者;P<0.0001)。

临床怎么用

  • 原文结论未据此给出临床推荐。

局限性

  • 纳入研究为观察性研究,存在严重局限性。
  • 证据存在不精确性。
  • 总体证据质量极低。
  • 男性伴侣感染的发现应谨慎解读,因其支持证据质量极低。
  • 现有证据仍不足以得出确切结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To identify, appraise and summarize the available data concerning the impact of human papilloma virus (HPV) infection on reproductive outcome following in-vitro fertilization (IVF). METHODS: We searched for studies in PubMed, EMBASE, Scopus, Lilacs and the Cochrane Central Register of Controlled Trials from inception to March 2017. Any type of HPV infection assessed through polymerase chain reaction, subfertility factors and IVF indications and protocols were considered. Our primary outcomes were live birth/ongoing pregnancy and miscarriage, while secondary outcomes included clinical and laboratory parameters. We planned subgroup analyses according to the status of cervical cytology and presence of infection in the male partner. We assessed the relative risk (RR), using a random-effects model; heterogeneity was assessed using the I2 statistic. Quality of the evidence was evaluated using the recommendations of the GRADE Working Group. RESULTS: From the 14 studies eligible for inclusion, quantitative data from 10, evaluating 299 women with HPV infection and 2049 women without HPV infection, were included in the analysis. The pooled results showed no significant difference between HPV-infected and non-infected women in rates of live birth/ongoing pregnancy (RR, 1.16 (95% CI, 0.88-1.53); I2 = 0%; six studies, 983 women), clinical pregnancy (RR, 1.06 (95% CI, 0.74-1.54); I2 = 61%; eight studies, 1173 women) or miscarriage (RR, 1.58 (95% CI, 0.93-2.69); I2 = 8%; six studies, 290 clinical pregnancies). The overall quality of the evidence was very low, downgraded two levels because of serious limitations of the included studies (observational studies) and imprecision. In contrast, pooled results in the subgroup analysis based on the presence of infection in the male partner showed significant differences in rates of live birth/ongoing pregnancy (RR, 0.43 (95% CI, 0.23-0.82); I2 = 0%; three studies, 429 participants; P = 0.01) and miscarriage (RR, 3.70 (95% CI, 1.94-7.05); I2 = 0%; two studies, 90 participants; P < 0.0001). CONCLUSIONS: The available evidence is still inadequate to enable us to draw firm conclusions regarding the effect of HPV infection in women on the most important reproductive outcomes following IVF; however, it suggests that the effect is not large for rates of live birth/ongoing pregnancy and clinical pregnancy. When infection is present in the male partner, it seems that there is a negative effect on live birth/ongoing pregnancy rate and an increase in miscarriage rate, a finding that should be interpreted with caution, owing to the very low quality of evidence supporting it. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Siristatidis C, Vaidakis D, Sertedaki E, et al. Effect of human papilloma virus infection on in-vitro fertilization outcome: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018. PMID: 28608497. doi:10.1002/uog.17550

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。